NEXIMMUNE has a total of 11 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Singapore, Australia and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD, DEISHER THERESA and ANTISOMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Jones Timothy David | 10 |
#2 | Carr Francis Joseph | 10 |
#3 | Mccreedy Bruce | 10 |
#4 | Francis Joseph Carr | 1 |
#5 | Timothy David Jones | 1 |
#6 | Bruce Mccreedy | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014209868A1 | Compositions and methods for immunotherapy |